HOME >> MEDICINE >> NEWS
Controversial drug shown to act on brain protein to cut alcohol use

A naturally occurring hallucinogen advocated by some clinicians as a potent anti-addiction drug has been rigorously studied for the first time, confirming its ability to block alcohol craving in rodents, and clarifying how it works in the brain. The new research findings about the drug Ibogaine open the way for development of other drugs to reverse addiction without Ibogaine's side effects, potentially adding to the small arsenal of drugs that effectively combat addiction.

Derived from a West African shrub, Ibogaine has been championed for years by a cadre of clinicians and drug treatment advocates impressed with its ability to reverse withdrawal symptoms and craving for alcohol and various drugs of abuse. It has been used outside of the U.S. to treat addiction by American and other clinicians. But its side effects, including hallucinations, which made it popular in the 1960s drug culture, and evidence of toxicity to certain nerve cells in rodent studies have discouraged careful studies of its clinical potential against drug and alcohol addiction. The FDA has not approved use of Ibogaine in the U.S.

Scientists at UCSF's Ernest Gallo Clinic and Research Center have now shown definitively in experiments with mice and rats that Ibogaine does reduce alcohol consumption, and they have determined that it does so by increasing the level of a brain protein known as glial cell line-derived neurotrophic factor, or GDNF. In a separate study, they demonstrated that GDNF by itself decreases alcohol consumption.

The research is being published in the January 19 issue of The Journal of Neuroscience.

"By identifying the brain protein that Ibogaine regulates to reduce alcohol consumption in rats, we have established a link between GDNF and reversal of addiction -- knowledge of a molecular mechanism that should allow development of a new class of drugs to treat addiction without Ibogaine's side effects," said Dorit Ron, PhD, UCSF associate professor of
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Jan-2005


Page: 1 2 3

Related medicine news :

1. Controversial Atkins Diet may be beneficial for people with epilepsy
2. Controversial performance enhancer "andro" affects brains as well as brawn, say UMass researchers
3. Cartilage repair techniques shown to restore patient mobility and reduce pain
4. Sprinklers shown effective in slowing dorm fires
5. HPV vaccine shown effective at reducing cancer-causing infections
6. HPV vaccine shown to substantially reduce cervical cancer
7. New research results: Heart jacket shown to be effective
8. Pioglitazone shown to reverse thickening of carotid artery wall
9. Isolated soy protein shown to benefit type 2 diabetics, study indicates
10. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
11. Increased risk of cardiovascular disease shown in PCOS patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... February 21, 2020 , ... The American ... Cancer Leaders’ Summit in Boston, MA, in October 2021. The prestigious, invitation-only event—organized ... including prime ministers, ministers of health, city and industry leaders, senior executives and ...
(Date:2/20/2020)... ... February 20, 2020 , ... Millennial women are flocking to cosmetic surgeons ... Milford, Penn requesting treatments to achieve “ Rich Girl Face .” In fact, Glamour ... is slowing down into 2020. It’s a look inspired by the signature bee-stung lips, ...
(Date:2/19/2020)... ... 2020 , ... The American College of Lifestyle Medicine (ACLM) ... Residency Curriculum (LMRC). The curriculum is the first comprehensive, applicable and flexible Lifestyle ... resident involvement, the curriculum has included residents in every aspect of its creation ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... consistency of healthcare delivery, announced that it will participate in the HIMSS20 ... Florida. BPM+ Health will engage healthcare professionals and other stakeholders at HIMSS20 – ...
(Date:2/16/2020)... ... February 16, 2020 , ... ... it is partnering with AABB and The Joint Commission to provide a complimentary ... PBM teams (directors, managers, coordinators and transfusion safety officers) within U.S. hospitals. ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... PLAINS, N.J. (PRWEB) , ... February 20, 2020 , ... ... new location at 27 Mountain Blvd. in Warren, NJ on Thursday, January 16 at ... staff and local elected officials for the ribbon-cutting ceremony. Members of the public and ...
(Date:2/20/2020)... ... February 20, 2020 , ... ... government program modernization, has been selected to perform Independent Verification and Validation ... (EOHHS) Health Insurance Exchange and Integrated Eligibility System (HIX/IES) project. , EOHHS, ...
(Date:2/19/2020)... ... February 19, 2020 , ... Cancer diagnostics ... diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as well ... for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, increasing 11.5% ...
Breaking Medicine Technology:
Cached News: